Jennifer Jarrett is currently chief operating officer and serves on the board of Arcus Biosciences, a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer. She currently serves on the boards of Syndax Pharmaceuticals and SMART, a non-profit organization, and previously served on the boards of Arena Pharmaceuticals and Audentes Therapeutics.

Jennifer previously served as vice president, corporate development and capital markets at Uber and as chief financial officer of Medivation. Prior to Medivation, Jennifer spent 20 years in investment banking, most recently at Citigroup, where she ran the firm’s west coast life sciences investment banking practice, and prior to that at Credit Suisse and Donaldson, Lufkin & Jenrette.

Jennifer holds a B.A. in economics from Dartmouth College and an M.B.A. from Stanford University Graduate School of Business.